NPORT-EX 1 QTLY_25_20190831.htm

Quarterly Holdings Report
for

Fidelity® Growth Company Fund

August 31, 2019







GCF-QTLY-1019
1.805820.115





Schedule of Investments August 31, 2019 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 98.0%   
 Shares Value (000s) 
COMMUNICATION SERVICES - 12.6%   
Diversified Telecommunication Services - 0.1%   
Verizon Communications, Inc. 798,276 $46,428 
Entertainment - 2.3%   
Activision Blizzard, Inc. 2,736,464 138,465 
Electronic Arts, Inc. (a) 933,896 87,487 
Lions Gate Entertainment Corp. Class A (b) 92,047 831 
Live Nation Entertainment, Inc. (a) 1,064,360 73,984 
NetEase, Inc. ADR 171,383 43,703 
Netflix, Inc. (a) 1,715,191 503,837 
Nintendo Co. Ltd. 71,900 27,207 
The Walt Disney Co. 891,138 122,318 
  997,832 
Interactive Media & Services - 9.4%   
Alphabet, Inc.:   
Class A (a) 1,442,662 1,717,532 
Class C (a) 782,372 929,536 
CarGurus, Inc. Class A (a) 368,431 12,018 
Facebook, Inc. Class A (a) 6,475,075 1,202,227 
Match Group, Inc. (b) 199,249 16,896 
Pinterest, Inc. Class A (b) 112,033 3,856 
Snap, Inc. Class A (a)(b) 4,525,971 71,646 
Tencent Holdings Ltd. 1,071,500 44,237 
Twitter, Inc. (a) 509,582 21,734 
  4,019,682 
Media - 0.2%   
Comcast Corp. Class A 2,046,692 90,587 
Turn, Inc. (Escrow) (a)(c)(d) 984,774 655 
  91,242 
Wireless Telecommunication Services - 0.6%   
T-Mobile U.S., Inc. (a) 3,019,016 235,634 
TOTAL COMMUNICATION SERVICES  5,390,818 
CONSUMER DISCRETIONARY - 21.0%   
Auto Components - 0.0%   
Garrett Motion, Inc. (a)(b) 123,272 1,213 
Automobiles - 0.6%   
Tesla, Inc. (a)(b) 1,118,805 252,414 
Hotels, Restaurants & Leisure - 1.3%   
Chipotle Mexican Grill, Inc. (a) 69,548 58,310 
Hyatt Hotels Corp. Class A (b) 204,953 14,787 
Marriott International, Inc. Class A 114,345 14,414 
McDonald's Corp. 355,672 77,526 
Planet Fitness, Inc. (a) 321,413 22,695 
Sea Ltd. ADR (a) 1,936,190 62,190 
Shake Shack, Inc. Class A (a) 156,290 15,498 
Starbucks Corp. 2,096,964 202,483 
YETI Holdings, Inc. (b) 180,119 5,088 
Yum China Holdings, Inc. 1,172,654 53,274 
Yum! Brands, Inc. 234,622 27,399 
  553,664 
Household Durables - 1.6%   
iRobot Corp. (a)(b) 657,277 40,626 
Roku, Inc. (a) 3,579,213 541,750 
Roku, Inc. Class A (a) 827,237 125,211 
  707,587 
Internet & Direct Marketing Retail - 8.8%   
Alibaba Group Holding Ltd. sponsored ADR (a) 1,026,526 179,673 
Amazon.com, Inc. (a) 1,566,061 2,781,782 
Chewy, Inc. (b) 185,449 6,120 
Ctrip.com International Ltd. ADR (a) 454,954 14,731 
eBay, Inc. 608,304 24,509 
Etsy, Inc. (a) 176,478 9,316 
Expedia, Inc. 197,234 25,660 
JD.com, Inc. sponsored ADR (a) 2,848,852 86,890 
Ocado Group PLC (a) 3,884,700 61,237 
The Booking Holdings, Inc. (a) 67,755 133,234 
The Honest Co., Inc. (a)(c)(d) 39,835 601 
The RealReal, Inc. (b) 448,612 5,863 
Wayfair LLC Class A (a)(b) 4,181,332 471,403 
  3,801,019 
Leisure Products - 0.0%   
Callaway Golf Co. 1,074,573 19,084 
Multiline Retail - 0.4%   
Dollar General Corp. 248,210 38,743 
Dollar Tree, Inc. (a) 991,117 100,628 
Ollie's Bargain Outlet Holdings, Inc. (a) 309,664 17,171 
Target Corp. 116,472 12,467 
  169,009 
Specialty Retail - 2.0%   
Carvana Co. Class A (a) 831,250 67,464 
Five Below, Inc. (a) 72,877 8,954 
Lowe's Companies, Inc. 1,558,229 174,833 
RH (a)(b) 854,326 122,382 
The Home Depot, Inc. 1,608,721 366,644 
Tiffany & Co., Inc. (b) 316,215 26,837 
TJX Companies, Inc. 1,368,649 75,235 
  842,349 
Textiles, Apparel & Luxury Goods - 6.3%   
adidas AG 2,472,539 732,895 
Allbirds, Inc. (c)(d) 61,486 2,853 
Canada Goose Holdings, Inc. (a)(b) 1,554,370 57,965 
lululemon athletica, Inc. (a)(e) 6,980,100 1,289,015 
NIKE, Inc. Class B 2,233,516 188,732 
Skechers U.S.A., Inc. Class A (sub. vtg.) (a) 9,578,470 303,254 
Tory Burch LLC Class B (a)(c)(d)(f) 1,275,684 72,574 
Under Armour, Inc. Class C (non-vtg.) (a) 719,945 12,181 
VF Corp. 340,591 27,911 
  2,687,380 
TOTAL CONSUMER DISCRETIONARY  9,033,719 
CONSUMER STAPLES - 4.2%   
Beverages - 2.2%   
Fever-Tree Drinks PLC 1,494,818 41,107 
Keurig Dr. Pepper, Inc. 4,710,332 128,498 
Monster Beverage Corp. (a) 5,751,888 337,463 
PepsiCo, Inc. 1,052,115 143,856 
The Coca-Cola Co. 5,396,139 297,003 
  947,927 
Food & Staples Retailing - 0.8%   
Costco Wholesale Corp. 745,115 219,630 
Kroger Co. 4,752,089 112,529 
  332,159 
Food Products - 0.4%   
Bunge Ltd. 1,530,549 81,747 
Darling International, Inc. (a) 1,607,796 29,905 
Mondelez International, Inc. 1,021,964 56,433 
The Hershey Co. 153,375 24,307 
  192,392 
Household Products - 0.3%   
Church & Dwight Co., Inc. 705,554 56,289 
Colgate-Palmolive Co. 308,232 22,855 
Kimberly-Clark Corp. 85,950 12,128 
Procter & Gamble Co. 132,481 15,928 
  107,200 
Personal Products - 0.2%   
Coty, Inc. Class A 4,735,184 45,221 
Godrej Consumer Products Ltd. 451,576 3,849 
Herbalife Nutrition Ltd. (a) 185,118 6,374 
Unilever NV 756,152 46,918 
  102,362 
Tobacco - 0.3%   
Altria Group, Inc. 2,046,640 89,520 
JUUL Labs, Inc. Class A (a)(c)(d) 44,067 12,559 
Philip Morris International, Inc. 213,404 15,384 
  117,463 
TOTAL CONSUMER STAPLES  1,799,503 
ENERGY - 1.2%   
Energy Equipment & Services - 0.0%   
Baker Hughes, A GE Co. Class A 610,235 13,236 
Oil, Gas & Consumable Fuels - 1.2%   
EOG Resources, Inc. 1,235,897 91,691 
Hess Corp. 3,865,391 243,326 
Noble Energy, Inc. 1,364,826 30,818 
PDC Energy, Inc. (a) 321,404 10,237 
Reliance Industries Ltd. 5,312,380 92,827 
Valero Energy Corp. 366,696 27,605 
  496,504 
TOTAL ENERGY  509,740 
FINANCIALS - 1.6%   
Banks - 0.7%   
Bank of America Corp. 1,761,070 48,447 
First Bancorp, Puerto Rico 1,229,254 11,776 
HDFC Bank Ltd. sponsored ADR 1,033,111 111,369 
JPMorgan Chase & Co. 892,096 98,006 
Signature Bank 65,898 7,687 
Wells Fargo & Co. 56,395 2,626 
  279,911 
Capital Markets - 0.7%   
BlackRock, Inc. Class A 232,362 98,187 
Charles Schwab Corp. 4,134,803 158,239 
Edelweiss Financial Services Ltd. 6,327,164 9,776 
T. Rowe Price Group, Inc. 229,115 25,345 
  291,547 
Consumer Finance - 0.2%   
American Express Co. 509,968 61,385 
Discover Financial Services 459,883 36,777 
  98,162 
Insurance - 0.0%   
Hiscox Ltd. 319,800 6,032 
TOTAL FINANCIALS  675,652 
HEALTH CARE - 16.9%   
Biotechnology - 10.2%   
AbbVie, Inc. 1,162,144 76,399 
ACADIA Pharmaceuticals, Inc. (a) 7,111,140 196,694 
Agios Pharmaceuticals, Inc. (a) 2,935,520 111,403 
Alector, Inc. (b) 486,232 8,003 
Alexion Pharmaceuticals, Inc. (a) 1,204,669 121,382 
Alkermes PLC (a) 2,309,059 48,444 
Allakos, Inc. (a) 212,325 18,782 
Allogene Therapeutics, Inc. (b) 944,704 25,724 
Allogene Therapeutics, Inc. (g) 301,764 8,217 
Alnylam Pharmaceuticals, Inc. (a) 5,334,623 430,451 
Amgen, Inc. 1,002,011 209,040 
AnaptysBio, Inc. (a) 513,603 20,878 
Argenx SE ADR (a) 155,358 20,422 
Ascendis Pharma A/S sponsored ADR (a) 34,354 3,849 
aTyr Pharma, Inc. 151,140 444 
Axcella Health, Inc. 370,689 2,569 
Axcella Health, Inc. 490,468 3,229 
BeiGene Ltd. 1,714,953 18,793 
BeiGene Ltd. ADR (a) 2,193,199 315,272 
Biogen, Inc. (a) 48,119 10,574 
bluebird bio, Inc. (a) 2,056,079 212,414 
Blueprint Medicines Corp. (a) 464,164 35,587 
Bridgebio Pharma, Inc. 307,189 9,363 
Calyxt, Inc. (a) 1,622,211 10,041 
Celgene Corp. (a) 687,609 66,561 
Cellectis SA sponsored ADR (a) 800,485 9,750 
ChemoCentryx, Inc. (a) 2,344,966 15,617 
Cibus Corp. Series C (a)(c)(d)(f) 7,264,850 11,043 
Coherus BioSciences, Inc. (a) 1,078,688 23,936 
Constellation Pharmaceuticals, Inc. (a) 597,523 4,332 
Crinetics Pharmaceuticals, Inc. (a) 200,199 3,175 
Denali Therapeutics, Inc. (a)(b) 617,687 11,118 
Eidos Therapeutics, Inc. (a)(b) 125,884 5,263 
Evelo Biosciences, Inc. (a)(b) 1,589,909 8,729 
Exact Sciences Corp. (a) 277,520 33,086 
Exelixis, Inc. (a) 6,112,765 121,338 
Fate Therapeutics, Inc. (a) 2,771,720 45,234 
Five Prime Therapeutics, Inc. (a) 242,818 1,319 
Fulcrum Therapeutics, Inc. 329,776 3,250 
Global Blood Therapeutics, Inc. (a) 910,038 41,844 
Homology Medicines, Inc. (a)(b) 1,027,761 19,435 
Intercept Pharmaceuticals, Inc. (a) 187,486 12,033 
Ionis Pharmaceuticals, Inc. (a)(e) 8,635,083 545,824 
Iovance Biotherapeutics, Inc. (a) 332,789 6,992 
Ironwood Pharmaceuticals, Inc. Class A (a) 3,933,177 36,618 
Jounce Therapeutics, Inc. (a) 89,901 339 
Kaleido Biosciences, Inc. (a)(b) 563,253 5,272 
Kaleido Biosciences, Inc. (g) 364,869 3,415 
Karuna Therapeutics, Inc. (a) 520,758 10,295 
Kiniksa Pharmaceuticals Ltd. (a) 111,110 981 
Lexicon Pharmaceuticals, Inc. (a)(b)(e) 6,157,978 8,129 
Macrogenics, Inc. (a) 396,016 5,679 
Mirati Therapeutics, Inc. (a) 305,105 25,009 
Moderna, Inc. (b) 5,665,336 89,116 
Momenta Pharmaceuticals, Inc. (a)(e) 6,184,237 78,107 
Neon Therapeutics, Inc. (a) 873,613 2,350 
Principia Biopharma, Inc. 184,777 7,336 
Protagonist Therapeutics, Inc. (a) 761,465 9,922 
Prothena Corp. PLC (a) 1,309,438 11,012 
Regeneron Pharmaceuticals, Inc. (a) 557,521 161,709 
Rigel Pharmaceuticals, Inc. (a)(e) 10,868,686 18,368 
Rubius Therapeutics, Inc. (a)(b) 3,704,787 34,380 
Sage Therapeutics, Inc. (a) 2,364,008 405,829 
Sarepta Therapeutics, Inc. (a) 331,261 29,863 
Scholar Rock Holding Corp. (a) 884,051 9,362 
Seres Therapeutics, Inc. (a) 3,221,856 12,984 
Sienna Biopharmaceuticals, Inc. (a)(e) 2,107,805 1,571 
Synthorx, Inc. 412,973 7,396 
Syros Pharmaceuticals, Inc. (a)(e) 1,292,893 14,183 
Syros Pharmaceuticals, Inc. (a)(e)(g) 938,007 10,290 
Syros Pharmaceuticals, Inc. warrants 10/10/22 (a)(d) 125,000 281 
The Medicines Company (a) 2,103,876 88,279 
Translate Bio, Inc. (a)(e) 2,741,214 24,890 
Ultragenyx Pharmaceutical, Inc. (a) 506,422 27,585 
uniQure B.V. (a) 878,831 47,677 
UNITY Biotechnology, Inc. (a)(b)(e) 2,323,888 14,176 
Vertex Pharmaceuticals, Inc. (a) 562,061 101,182 
Wuxi Biologics (Cayman), Inc. (a)(g) 3,971,000 41,677 
Xencor, Inc. (a) 1,327,158 49,476 
Zai Lab Ltd. ADR (a) 2,087,068 68,059 
  4,370,650 
Health Care Equipment & Supplies - 3.9%   
Abbott Laboratories 994,984 84,892 
Boston Scientific Corp. (a) 2,253,786 96,304 
Danaher Corp. 1,310,019 186,141 
DexCom, Inc. (a) 862,356 147,989 
Genmark Diagnostics, Inc. (a) 1,404,463 8,413 
Insulet Corp. (a) 1,868,476 288,063 
Intuitive Surgical, Inc. (a) 459,377 234,898 
Novocure Ltd. (a) 4,065,618 369,402 
Novocure Ltd. (a)(g) 571,461 51,923 
Penumbra, Inc. (a) 982,752 143,040 
Presbia PLC (a)(e) 1,222,614 66 
Shockwave Medical, Inc. (a)(b) 397,731 16,645 
Shockwave Medical, Inc. 443,695 18,383 
Stryker Corp. 167,911 37,051 
Wright Medical Group NV (a) 439,445 9,162 
  1,692,372 
Health Care Providers & Services - 1.0%   
Centene Corp. (a) 379,886 17,710 
G1 Therapeutics, Inc. (a) 330,460 11,996 
Humana, Inc. 59,079 16,732 
Laboratory Corp. of America Holdings (a) 68,052 11,403 
Notre Dame Intermedica Participacoes SA 1,511,700 20,472 
OptiNose, Inc. (a)(b)(e) 1,554,753 11,909 
OptiNose, Inc. (a)(e)(g) 992,571 7,603 
UnitedHealth Group, Inc. 1,407,839 329,434 
  427,259 
Health Care Technology - 0.1%   
Castlight Health, Inc. Class B (a) 1,552,364 2,189 
Health Catalyst, Inc. (b) 123,806 4,935 
Karuna Therapeutics, Inc. 365,628 6,506 
Livongo Health, Inc. (b) 95,205 2,917 
Teladoc Health, Inc. (a)(b) 223,398 12,930 
  29,477 
Life Sciences Tools & Services - 0.3%   
Adaptive Biotechnologies Corp. (b) 165,130 8,397 
Bruker Corp. 131,800 5,690 
Illumina, Inc. (a) 47,032 13,232 
Thermo Fisher Scientific, Inc. 330,249 94,801 
  122,120 
Pharmaceuticals - 1.4%   
Adimab LLC (a)(c)(d)(f) 3,162,765 146,025 
Akcea Therapeutics, Inc. (a)(b)(e) 5,490,530 115,631 
Bristol-Myers Squibb Co. 601,753 28,926 
Corteva, Inc. 189,305 5,550 
Cyclerion Therapeutics, Inc. (a) 450,961 4,289 
Cyclerion Therapeutics, Inc. (c) 543,695 5,171 
Fulcrum Therapeutics, Inc. 279,067 3,056 
Hansoh Pharmaceutical Group Co. Ltd. (g) 3,528,000 11,887 
Hookipa Pharma, Inc. 146,426 1,236 
Intra-Cellular Therapies, Inc. (a)(e) 2,810,492 24,058 
Jiangsu Hengrui Medicine Co. Ltd. (A Shares) 214,320 2,397 
Morphic Holding, Inc. 353,920 6,548 
MyoKardia, Inc. (a) 1,764,551 94,880 
Nektar Therapeutics (a) 5,248,108 92,209 
Rhythm Pharmaceuticals, Inc. (a) 401,467 9,041 
RPI International Holdings LP (a)(c)(d) 130,847 20,020 
Stemcentrx, Inc. rights 12/31/21 (a)(d) 2,065,715 0 
Theravance Biopharma, Inc. (a) 1,576,156 34,723 
Turning Point Therapeutics, Inc. 248,160 13,532 
  619,179 
TOTAL HEALTH CARE  7,261,057 
INDUSTRIALS - 4.6%   
Aerospace & Defense - 1.2%   
Lockheed Martin Corp. 95,102 36,530 
Space Exploration Technologies Corp. Class A (a)(c)(d) 418,210 89,497 
The Boeing Co. 931,771 339,249 
United Technologies Corp. 407,964 53,133 
  518,409 
Air Freight & Logistics - 0.2%   
FedEx Corp. 28,216 4,475 
United Parcel Service, Inc. Class B 623,762 74,016 
  78,491 
Airlines - 1.1%   
Azul SA sponsored ADR (a) 425,664 14,949 
Delta Air Lines, Inc. 610,684 35,334 
JetBlue Airways Corp. (a) 4,225,477 73,185 
Ryanair Holdings PLC sponsored ADR (a) 441,731 25,311 
Southwest Airlines Co. 1,450,892 75,911 
Spirit Airlines, Inc. (a) 395,492 14,847 
United Continental Holdings, Inc. (a) 666,849 56,222 
Wheels Up Partners Holdings LLC Series B (a)(c)(d)(f) 12,825,647 44,633 
Wizz Air Holdings PLC (a)(g) 2,634,184 115,262 
  455,654 
Building Products - 0.0%   
Resideo Technologies, Inc. (a) 1,078,576 14,863 
Electrical Equipment - 0.2%   
AMETEK, Inc. 22,519 1,935 
Eaton Corp. PLC 262,767 21,211 
Emerson Electric Co. 368,971 21,987 
Fortive Corp. 425,452 30,165 
  75,298 
Industrial Conglomerates - 0.6%   
3M Co. 365,760 59,151 
Honeywell International, Inc. 1,146,671 188,765 
  247,916 
Machinery - 0.5%   
Deere & Co. 568,833 88,118 
Illinois Tool Works, Inc. 267,023 40,016 
Ingersoll-Rand PLC 122,117 14,787 
Xylem, Inc. 1,104,630 84,626 
  227,547 
Professional Services - 0.0%   
CoStar Group, Inc. (a) 24,803 15,251 
Verisk Analytics, Inc. 12,500 2,019 
  17,270 
Road & Rail - 0.8%   
Lyft, Inc. 788,745 38,625 
Uber Technologies, Inc. 4,979,396 154,070 
Union Pacific Corp. 1,019,114 165,056 
  357,751 
TOTAL INDUSTRIALS  1,993,199 
INFORMATION TECHNOLOGY - 35.0%   
Communications Equipment - 0.5%   
Arista Networks, Inc. (a) 141,886 32,154 
Ciena Corp. (a) 292,905 11,989 
Cisco Systems, Inc. 1,184,318 55,438 
Infinera Corp. (a)(e) 12,995,774 69,267 
NETGEAR, Inc. (a) 1,234,114 42,848 
  211,696 
Electronic Equipment & Components - 0.2%   
Arlo Technologies, Inc. (e) 5,356,225 16,819 
TE Connectivity Ltd. 80,703 7,362 
Trimble, Inc. (a) 1,113,291 41,771 
  65,952 
Internet Software & Services - 0.0%   
Farfetch Ltd. Class A (b) 724,651 7,087 
IT Services - 8.1%   
Actua Corp. (a)(d)(e) 1,708,572 478 
Adyen BV (a)(g) 7,363 5,331 
Dynatrace, Inc. 138,362 3,180 
Elastic NV 206,209 18,124 
Fastly, Inc. Class A (b) 88,849 2,808 
IBM Corp. 75,692 10,259 
MasterCard, Inc. Class A 2,041,071 574,296 
MongoDB, Inc. (a) 665,802 101,408 
MongoDB, Inc. Class A (a)(b) 250,458 38,147 
Okta, Inc. (a) 339,733 42,976 
PayPal Holdings, Inc. (a) 5,250,192 572,533 
Shopify, Inc. Class A (a) 3,142,396 1,210,368 
Square, Inc. (a) 2,413,242 149,235 
Visa, Inc. Class A 3,657,888 661,419 
Wix.com Ltd. (a) 472,619 66,285 
  3,456,847 
Semiconductors & Semiconductor Equipment - 8.1%   
Advanced Micro Devices, Inc. (a)(b) 11,262,494 354,205 
Applied Materials, Inc. 1,303,626 62,600 
ASML Holding NV 313,553 69,800 
Broadcom, Inc. 211,097 59,664 
Cirrus Logic, Inc. (a) 601,741 32,277 
Cree, Inc. (a) 699,274 30,020 
Intel Corp. 72,024 3,415 
KLA-Tencor Corp. 211,846 31,332 
Marvell Technology Group Ltd. 2,619,217 62,783 
Micron Technology, Inc. (a) 1,688,209 76,425 
NVIDIA Corp. 11,968,097 2,004,776 
Qualcomm, Inc. 795,283 61,849 
Silicon Laboratories, Inc. (a)(e) 3,172,982 345,855 
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR 1,104,784 47,097 
Texas Instruments, Inc. 1,381,952 171,017 
Xilinx, Inc. 714,888 74,391 
  3,487,506 
Software - 12.8%   
2U, Inc. (a)(b) 374,391 6,694 
Adobe, Inc. (a) 1,516,037 431,328 
Atlassian Corp. PLC (a) 402,370 54,123 
Autodesk, Inc. (a) 1,453,994 207,659 
Avalara, Inc. (a) 58,522 4,936 
Black Knight, Inc. (a) 482,286 30,022 
Cadence Design Systems, Inc. (a) 270,519 18,525 
Coupa Software, Inc. (a) 520,544 72,319 
Crowdstrike Holdings, Inc. (b) 133,911 10,884 
CyberArk Software Ltd. (a) 119,994 13,480 
DocuSign, Inc. (a) 58,925 2,751 
HubSpot, Inc. (a) 1,493,263 298,175 
Intuit, Inc. 488,785 140,946 
LivePerson, Inc. (a) 1,231,455 48,938 
Medallia, Inc. (b) 272,465 9,705 
Microsoft Corp. 13,415,501 1,849,461 
Nutanix, Inc.:   
Class A (a) 8,889,283 215,387 
Class B (a)(g) 1,151,309 27,896 
Oracle Corp. 1,686,153 87,781 
Pagerduty, Inc. (b) 68,528 2,691 
Paylocity Holding Corp. (a) 115,069 12,568 
Proofpoint, Inc. (a) 312,274 35,477 
Q2 Holdings, Inc. (a) 448,666 40,358 
RingCentral, Inc. (a) 53,598 7,564 
Salesforce.com, Inc. (a) 9,657,370 1,507,226 
Sciplay Corp. (A Shares) 33,311 317 
Smartsheet, Inc. (a) 395,879 19,240 
Tenable Holdings, Inc. (a) 76,501 1,744 
Workday, Inc. Class A (a) 123,193 21,840 
Zendesk, Inc. (a) 1,871,933 150,129 
Zoom Video Communications, Inc. Class A (b) 60,177 5,516 
Zscaler, Inc. (a) 2,650,789 182,215 
  5,517,895 
Technology Hardware, Storage & Peripherals - 5.3%   
Apple, Inc. 10,146,634 2,118,008 
Pure Storage, Inc. Class A (a) 8,414,604 136,990 
Samsung Electronics Co. Ltd. 885,615 32,195 
  2,287,193 
TOTAL INFORMATION TECHNOLOGY  15,034,176 
MATERIALS - 0.5%   
Chemicals - 0.3%   
CF Industries Holdings, Inc. 1,542,372 74,327 
Dow, Inc. 189,305 8,070 
DowDuPont, Inc. 141,002 9,578 
LG Chemical Ltd. 9,697 2,648 
The Mosaic Co. 241,457 4,440 
  99,063 
Metals & Mining - 0.2%   
Barrick Gold Corp. (Canada) 4,955,800 96,071 
TOTAL MATERIALS  195,134 
REAL ESTATE - 0.4%   
Equity Real Estate Investment Trusts (REITs) - 0.4%   
American Tower Corp. 624,680 143,795 
Ant International Co. Ltd. Class C (a)(c)(d) 1,658,265 11,940 
  155,735 
UTILITIES - 0.0%   
Electric Utilities - 0.0%   
ORSTED A/S (g) 188,000 17,951 
TOTAL COMMON STOCKS   
(Cost $18,531,504)  42,066,684 
Preferred Stocks - 1.8%   
Convertible Preferred Stocks - 1.6%   
COMMUNICATION SERVICES - 0.0%   
Wireless Telecommunication Services - 0.0%   
Altiostar Networks, Inc. Series A1 (a)(c)(d) 699,106 1,720 
CONSUMER DISCRETIONARY - 0.2%   
Hotels, Restaurants & Leisure - 0.1%   
MOD Super Fast Pizza Holdings LLC Series 3 (a)(c)(d)(f) 82,137 11,706 
Neutron Holdings, Inc. Series D (c)(d) 17,893,728 4,339 
Topgolf International, Inc. Series F (a)(c)(d) 819,532 13,703 
  29,748 
Internet & Direct Marketing Retail - 0.0%   
Reddit, Inc. Series B (a)(c)(d) 384,303 8,334 
The Honest Co., Inc.:   
Series C (a)(c)(d) 92,950 3,593 
Series D (a)(c)(d) 69,363 3,174 
  15,101 
Leisure Products - 0.1%   
Peloton Interactive, Inc. Series E (a)(c)(d) 2,549,928 54,262 
Textiles, Apparel & Luxury Goods - 0.0%   
Allbirds, Inc.:   
Series A (c)(d) 24,267 1,126 
Series B (c)(d) 4,263 198 
Series C (c)(d) 40,746 1,891 
ORIC Pharmaceuticals, Inc.:   
Series C (a)(c)(d) 1,416,666 4,675 
Series D (c)(d) 175,319 579 
  8,469 
TOTAL CONSUMER DISCRETIONARY  107,580 
CONSUMER STAPLES - 0.1%   
Food & Staples Retailing - 0.1%   
Sweetgreen, Inc. Series H (c)(d) 705,259 11,242 
Food Products - 0.0%   
Agbiome LLC Series C (a)(c)(d) 1,060,308 5,747 
Tobacco - 0.0%   
JUUL Labs, Inc. Series E (a)(c)(d) 22,033 6,279 
TOTAL CONSUMER STAPLES  23,268 
FINANCIALS - 0.0%   
Insurance - 0.0%   
Clover Health Series D (a)(c)(d) 863,631 8,099 
HEALTH CARE - 0.7%   
Biotechnology - 0.6%   
10X Genomics, Inc.:   
Series C (a)(c) 2,505,940 38,090 
Series D (a)(c) 364,100 5,534 
23andMe, Inc. Series F (a)(c)(d) 590,383 8,035 
BioNTech AG:   
Series A (a)(c)(d) 114,025 35,911 
Series B (d) 72,156 22,725 
Generation Bio Series B (a)(c)(d) 831,800 7,561 
Immunocore Ltd. Series A (a)(c)(d) 67,323 7,976 
Intarcia Therapeutics, Inc.:   
Series CC (a)(c)(d) 1,051,411 42,519 
Series DD (a)(c)(d) 1,543,687 62,427 
Nuvation Bio, Inc. Series A (c)(d)(h) 13,044,100 10,062 
  240,840 
Health Care Providers & Services - 0.0%   
Mulberry Health, Inc. Series A8 (a)(c)(d) 2,790,742 19,647 
Health Care Technology - 0.0%   
Codiak Biosciences, Inc.:   
Series A 8.00% (a)(c)(d) 589,863 2,141 
Series B 8.00% (a)(c)(d) 1,917,058 6,959 
Series C, 8.00% (a)(c)(d) 2,688,186 9,758 
  18,858 
Pharmaceuticals - 0.1%   
Allovir, Inc. Series B (c)(d) 1,225,771 9,990 
Castle Creek Pharmaceutical Holdings, Inc. Series B (c)(d) 16,803 7,069 
Harmony Biosciences II, Inc.:   
Series A (a)(c)(d) 10,934,380 21,431 
Series C (c)(d) 2,033,272 3,985 
Nohla Therapeutics, Inc. Series B (a)(c)(d) 9,124,200 0 
  42,475 
TOTAL HEALTH CARE  321,820 
INDUSTRIALS - 0.2%   
Aerospace & Defense - 0.1%   
Space Exploration Technologies Corp. Series G (a)(c)(d) 216,276 46,283 
Professional Services - 0.1%   
YourPeople, Inc. Series C (a)(c)(d) 5,833,137 22,108 
TOTAL INDUSTRIALS  68,391 
INFORMATION TECHNOLOGY - 0.4%   
Internet Software & Services - 0.1%   
Starry, Inc.:   
Series B (a)(c)(d) 9,869,159 14,113 
Series C (a)(c)(d) 5,234,614 7,485 
Series D (c)(d) 5,078,764 7,263 
  28,861 
IT Services - 0.0%   
AppNexus, Inc. Series E (Escrow) (a)(c)(d) 923,523 891 
Software - 0.3%   
Bird Rides, Inc. Series C (c)(d) 348,328 4,091 
Cloudflare, Inc. Series D, 8.00% (a)(c)(d) 2,229,826 39,691 
Dataminr, Inc. Series D (a)(c)(d) 1,773,901 32,888 
Jet.Com, Inc. Series B1 (Escrow) (a)(c)(d) 7,578,338 0 
Outset Medical, Inc.:   
Series C (a)(c)(d) 1,244,716 3,871 
Series D (c)(d) 1,525,901 4,746 
Taboola.Com Ltd. Series E (a)(c)(d) 1,337,420 33,649 
UiPath, Inc.:   
Series A1 (c)(d) 195,690 7,701 
Series B1 (c)(d) 9,749 384 
Series B2 (c)(d) 48,550 1,911 
  128,932 
TOTAL INFORMATION TECHNOLOGY  158,684 
REAL ESTATE - 0.0%   
Real Estate Management & Development - 0.0%   
Sonder Canada, Inc. Series D (c)(d) 965,896 10,138 
TOTAL CONVERTIBLE PREFERRED STOCKS  699,700 
Nonconvertible Preferred Stocks - 0.2%   
CONSUMER DISCRETIONARY - 0.0%   
Textiles, Apparel & Luxury Goods - 0.0%   
Allbirds, Inc. (c)(d) 13,038 605 
ENERGY - 0.1%   
Oil, Gas & Consumable Fuels - 0.1%   
Petroleo Brasileiro SA - Petrobras (PN) sponsored ADR (non-vtg.) 3,064,524 37,479 
FINANCIALS - 0.0%   
Banks - 0.0%   
Itau Unibanco Holding SA 1,507,700 12,357 
HEALTH CARE - 0.1%   
Biotechnology - 0.0%   
Yumanity Holdings LLC:   
Class A (a)(c)(d) 464,607 3,062 
Class B (a)(c)(d) 336,308 2,216 
  5,278 
Pharmaceuticals - 0.1%   
Castle Creek Pharmaceutical Holdings, Inc. Series A4 (c)(d) 46,864 19,715 
TOTAL HEALTH CARE  24,993 
TOTAL NONCONVERTIBLE PREFERRED STOCKS  75,434 
TOTAL PREFERRED STOCKS   
(Cost $612,231)  775,134 
 Principal Amount (000s) Value (000s) 
Preferred Securities - 0.0%   
HEALTH CARE - 0.0%   
Biotechnology - 0.0%   
Intarcia Therapeutics, Inc. 6% 7/18/21(c)(d)   
(Cost $13,682) 13,682 13,682 
 Shares Value (000s) 
Money Market Funds - 2.0%   
Fidelity Cash Central Fund 2.13%(i) 74,283,653 74,299 
Fidelity Securities Lending Cash Central Fund 2.13% (i)(j) 785,788,184 785,867 
TOTAL MONEY MARKET FUNDS   
(Cost $860,157)  860,166 
TOTAL INVESTMENT IN SECURITIES - 101.8%   
(Cost $20,017,574)  43,715,666 
NET OTHER ASSETS (LIABILITIES) - (1.8)%  (763,099) 
NET ASSETS - 100%  $42,952,567 

Values shown as $0 in the Schedule of Investments may reflect amounts less than $500.

Legend

 (a) Non-income producing

 (b) Security or a portion of the security is on loan at period end.

 (c) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $1,133,826,000 or 2.6% of net assets.

 (d) Level 3 security

 (e) Affiliated company

 (f) Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

 (g) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $301,452,000 or 0.7% of net assets.

 (h) Security or a portion of the security purchased on a delayed delivery or when-issued basis.

 (i) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

 (j) Includes investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:

Security Acquisition Date Acquisition Cost (000s) 
10X Genomics, Inc. Series C 2/23/16 - 4/3/17 $11,222 
10X Genomics, Inc. Series D 4/10/18 $3,484 
23andMe, Inc. Series F 8/31/17 $8,197 
Adimab LLC 9/17/14 - 6/5/15 $48,959 
Agbiome LLC Series C 6/29/18 $6,716 
Allbirds, Inc. 10/9/18 $3,372 
Allbirds, Inc. 10/9/18 $715 
Allbirds, Inc. Series A 10/9/18 $1,331 
Allbirds, Inc. Series B 10/9/18 $234 
Allbirds, Inc. Series C 10/9/18 $2,234 
Allovir, Inc. Series B 5/8/19 $9,990 
Altiostar Networks, Inc. Series A1 1/10/17 $3,216 
Ant International Co. Ltd. Class C 5/16/18 $9,303 
AppNexus, Inc. Series E (Escrow) 8/1/14 $1,665 
BioNTech AG Series A 12/29/17 $24,972 
Bird Rides, Inc. Series C 12/21/18 $4,091 
Castle Creek Pharmaceutical Holdings, Inc. Series A4 9/29/16 $15,506 
Castle Creek Pharmaceutical Holdings, Inc. Series B 10/9/18 $6,920 
Cibus Corp. Series C 2/16/18 - 5/10/19 $12,927 
Cloudflare, Inc. Series D, 8.00% 11/5/14 - 9/10/18 $17,559 
Clover Health Series D 6/7/17 $8,099 
Codiak Biosciences, Inc. Series A 8.00% 11/12/15 $590 
Codiak Biosciences, Inc. Series B 8.00% 11/12/15 $5,751 
Codiak Biosciences, Inc. Series C, 8.00% 11/17/17 $10,182 
Cyclerion Therapeutics, Inc. 4/2/19 $8,052 
Dataminr, Inc. Series D 2/18/15 - 3/6/15 $22,617 
Generation Bio Series B 2/21/18 $7,607 
Harmony Biosciences II, Inc. Series A 9/22/17 $10,934 
Harmony Biosciences II, Inc. Series C 8/9/19 $3,985 
Immunocore Ltd. Series A 7/27/15 $12,669 
Intarcia Therapeutics, Inc. Series CC 11/14/12 $14,331 
Intarcia Therapeutics, Inc. Series DD 3/17/14 $50,000 
Intarcia Therapeutics, Inc. 6% 7/18/21 2/26/19 $13,682 
Jet.Com, Inc. Series B1 (Escrow) 3/19/18 $0 
JUUL Labs, Inc. Class A 7/6/18 $1,299 
JUUL Labs, Inc. Series E 7/6/18 $650 
MOD Super Fast Pizza Holdings LLC Series 3 11/3/16 - 5/15/19 $11,436 
Mulberry Health, Inc. Series A8 1/20/16 $18,851 
Neutron Holdings, Inc. Series D 1/25/19 $4,339 
Nohla Therapeutics, Inc. Series B 5/1/18 $4,161 
Nuvation Bio, Inc. Series A 6/17/19 $10,062 
ORIC Pharmaceuticals, Inc. Series C 2/6/18 $4,250 
ORIC Pharmaceuticals, Inc. Series D 6/28/19 $579 
Outset Medical, Inc. Series C 4/19/17 $3,226 
Outset Medical, Inc. Series D 8/20/18 $4,746 
Peloton Interactive, Inc. Series E 3/31/17 $13,809 
Reddit, Inc. Series B 7/26/17 $5,456 
RPI International Holdings LP 5/21/15 - 3/23/16 $16,269 
Sonder Canada, Inc. Series D 5/21/19 $10,138 
Space Exploration Technologies Corp. Class A 10/16/15 - 4/6/17 $38,201 
Space Exploration Technologies Corp. Series G 1/20/15 $16,753 
Starry, Inc. Series B 12/1/16 $5,339 
Starry, Inc. Series C 12/8/17 $4,826 
Starry, Inc. Series D 3/6/19 $7,263 
Sweetgreen, Inc. Series H 11/9/18 $9,197 
Taboola.Com Ltd. Series E 12/22/14 $13,943 
The Honest Co., Inc. 8/21/14 $1,078 
The Honest Co., Inc. Series C 8/21/14 $2,515 
The Honest Co., Inc. Series D 8/3/15 $3,174 
Topgolf International, Inc. Series F 11/10/17 $11,337 
Tory Burch LLC Class B 12/31/12 - 5/14/15 $83,535 
Turn, Inc. (Escrow) 4/11/17 $591 
UiPath, Inc. Series A1 6/14/19 $7,701 
UiPath, Inc. Series B1 6/14/19 $384 
UiPath, Inc. Series B2 6/14/19 $1,911 
Wheels Up Partners Holdings LLC Series B 9/18/15 - 5/16/19 $39,133 
YourPeople, Inc. Series C 5/1/15 $86,920 
Yumanity Holdings LLC Class A 2/8/16 $3,140 
Yumanity Holdings LLC Class B 6/19/18 $2,815 

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
 (Amounts in thousands) 
Fidelity Cash Central Fund $1,246 
Fidelity Securities Lending Cash Central Fund $8,744 
Total $9,990 

Amounts in the income column in the above table include any capital gain distributions from underlying funds. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.

Other Affiliated Issuers

An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities. Fiscal year to date transactions with companies which are or were affiliates are as follows:

Affiliate (Amounts in thousands) Value, beginning of period Purchases Sales Proceeds Dividend Income Realized Gain (loss) Change in Unrealized appreciation (depreciation) Value, end of period 
ACADIA Pharmaceuticals, Inc. $138,324 $3,308 $6,524 $-- $5,334 $56,252 $-- 
Actua Corp. 1,135 -- 49 -- 49 (657) 478 
Akcea Therapeutics, Inc. 177,899 19,794 10,936 -- 3,024 (74,150) 115,631 
Alkermes PLC 291,143 -- 166,051 -- (6,797) (69,851) -- 
Alnylam Pharmaceuticals, Inc. 411,703 37,011 15,405 -- 8,741 (11,599) -- 
Arlo Technologies, Inc. 43,020 69 16,765 -- (35,651) (27,815) 16,819 
aTyr Pharma, Inc. 1,353 -- 33 -- (400) (476) -- 
Calyxt, Inc. 19,399 -- 682 -- 188 (8,864) -- 
Evelo Biosciences, Inc. 9,020 -- -- -- -- 2,960 -- 
Evelo Biosciences, Inc. 6,669 424 351 -- (4) (9,989) -- 
Infinera Corp. 56,075 2,094 2,001 -- (101) 13,200 69,267 
Intra-Cellular Therapies, Inc. 54,509 -- 9,668 -- (28,044) 7,261 24,058 
Ionis Pharmaceuticals, Inc. 465,471 66,338 20,372 -- 15,136 19,251 545,824 
Lexicon Pharmaceuticals, Inc. 53,573 1,155 3,346 -- (3,739) (39,514) 8,129 
lululemon athletica, Inc. 959,027 5,143 46,248 -- 38,502 332,591 1,289,015 
Momenta Pharmaceuticals, Inc. 60,109 15,358 2,838 -- 275 5,203 78,107 
NETGEAR, Inc. 130,806 511 38,535 -- (8,530) 12,557 -- 
OptiNose, Inc. 10,454 2,259 434 -- (13) (357) 11,909 
OptiNose, Inc. 7,812 -- -- -- -- (209) 7,603 
Presbia PLC 888 7 13 -- (100) (716) 66 
Rigel Pharmaceuticals, Inc. 32,270 795 1,866 -- (3,693) (9,138) 18,368 
Seres Therapeutics, Inc. 12,834 2,702 350 -- 15 (9,185) -- 
Seres Therapeutics, Inc. 4,783 -- -- -- -- 2,184 -- 
Sienna Biopharmaceuticals, Inc. 8,483 2,415 88 -- (102) (16,039) 1,571 
Sienna Biopharmaceuticals, Inc. 5,702 -- -- -- -- 1,200 -- 
Silicon Laboratories, Inc. 279,754 14,288 14,049 -- 5,601 60,261 345,855 
Syros Pharmaceuticals, Inc. 8,321 4,541 3,381 -- (3,631) 8,333 14,183 
Syros Pharmaceuticals, Inc. 6,388 -- -- -- -- 3,902 10,290 
Translate Bio, Inc. 3,037 3,266 370 -- 114 882 24,890 
Translate Bio, Inc. 13,693 -- -- -- -- 4,268 -- 
UNITY Biotechnology, Inc. 15,350 -- -- -- -- 543 -- 
UNITY Biotechnology, Inc. 8,762 6,556 556 -- 19 (16,498) 14,176 
Total $3,297,766 $188,034 $360,911 $-- $(13,807) $235,791 $2,596,239 

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.